Filing Flows › Lucid Diagnostics (LUCD) › Q2 2025
Lucid Diagnostics (LUCD) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 12, 2025
Lucid Diagnostics (LUCD) reported revenue of $1.2M for the second quarter 2025 (Q2 2025), +19% from a year earlier and +40% from the quarter before. Operating margin was -978.8%, net loss $4.4M (381.7% of revenue).
Lucid Diagnostics, Q2 2025: revenue $1.2M (+19% year over year), operating margin -978.8%, net loss $4.4M, operating cash flow −$10.5M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2M | +40% | +19% |
| Operating profit | −$11.4M | — | — |
| Net earnings | −$4.4M | — | — |
| Operating cash flow | −$10.5M | — | — |
What changed
Revenue was $1.2M in Q2 2025, up 19% year over year and up 40% from the previous quarter.
Operating costs exceeded revenue by $11.4M, an operating margin of -978.8%. Total costs grew 3% against revenue growth of 19%. The fastest-growing cost line was General & admin (+15%). The quarter ended with a net loss of $4.4M, narrower than the previous quarter's $26.9M loss. Non-operating items added $6.9M, -156% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$10.5M. Non-cash charges added back $222K of depreciation and amortization and $1.1M of share-based compensation. Working capital and other items used $7.5M. Capital expenditures of $25K exceeded it, leaving free cash flow of −$10.6M.
Questions
What was Lucid Diagnostics' revenue in the second quarter 2025?
Lucid Diagnostics (LUCD) reported revenue of $1.2M for the second quarter 2025 (Q2 2025), +19% from a year earlier and +40% from the quarter before.
Was Lucid Diagnostics profitable in the second quarter 2025?
Operating loss was $11.4M (-978.8% of revenue) and net loss $4.4M.
Source: Lucid Diagnostics 10-Q on SEC EDGAR.